{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T06:18:50Z","timestamp":1780553930688,"version":"3.54.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T00:00:00Z","timestamp":1707264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T00:00:00Z","timestamp":1707264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurocrit Care"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s12028-023-01928-6","type":"journal-article","created":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T21:22:51Z","timestamp":1707340971000},"page":"174-184","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Cerebral Hemodynamics and Levosimendan Use in Patients with Cerebral Vasospasm and Subarachnoid Hemorrhage: An Observational Perfusion CT-Based Imaging Study"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4275-4383","authenticated-orcid":false,"given":"Gr\u00e9goire","family":"Cane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugues","family":"de Courson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Robert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hikaru","family":"Fukutomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaultier","family":"Marnat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Tourdias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Biais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,7]]},"reference":[{"issue":"15","key":"1928_CR1","doi-asserted-by":"publisher","first-page":"e021845","DOI":"10.1161\/JAHA.121.021845","volume":"10","author":"WS Dodd","year":"2021","unstructured":"Dodd WS, Laurent D, Dumont AS, et al. Pathophysiology of delayed cerebral ischemia after subarachnoid hemorrhage: a review. J Am Heart Assoc. 2021;10(15):e021845. https:\/\/doi.org\/10.1161\/JAHA.121.021845.","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"1928_CR2","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nrneurol.2013.246","volume":"10","author":"RL Macdonald","year":"2014","unstructured":"Macdonald RL. Delayed neurological deterioration after subarachnoid haemorrhage. Nat Rev Neurol. 2014;10(1):44\u201358. https:\/\/doi.org\/10.1038\/nrneurol.2013.246.","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"1928_CR3","doi-asserted-by":"publisher","first-page":"E175","DOI":"10.1093\/neuros\/nyz340","volume":"86","author":"J Brami","year":"2020","unstructured":"Brami J, Chousterman B, Boulouis G, et al. Delayed cerebral infarction is systematically associated with a cerebral vasospasm of large intracranial arteries. Neurosurgery. 2020;86(2):E175\u201383. https:\/\/doi.org\/10.1093\/neuros\/nyz340.","journal-title":"Neurosurgery"},{"key":"1928_CR4","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.wneu.2019.03.083","volume":"126","author":"K Li","year":"2019","unstructured":"Li K, Barras CD, Chandra RV, et al. A review of the management of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. World Neurosurg. 2019;126:513\u201327. https:\/\/doi.org\/10.1016\/j.wneu.2019.03.083.","journal-title":"World Neurosurg"},{"key":"1928_CR5","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.15420\/cfr.2020.03","volume":"6","author":"Z Papp","year":"2020","unstructured":"Papp Z, Agostoni P, Alvarez J, et al. Levosimendan efficacy and safety: 20 years of SIMDAX in clinical use. Card Fail Rev. 2020;6:e19. https:\/\/doi.org\/10.15420\/cfr.2020.03.","journal-title":"Card Fail Rev"},{"issue":"7","key":"1928_CR6","doi-asserted-by":"publisher","first-page":"535","DOI":"10.2165\/00003088-200746070-00001","volume":"46","author":"S Antila","year":"2007","unstructured":"Antila S, Sundberg S, Lehtonen LA. Clinical pharmacology of levosimendan. Clin Pharmacokinet. 2007;46(7):535\u201352. https:\/\/doi.org\/10.2165\/00003088-200746070-00001.","journal-title":"Clin Pharmacokinet"},{"issue":"4","key":"1928_CR7","first-page":"227","volume":"5","author":"MS Nieminen","year":"2013","unstructured":"Nieminen MS, Fruhwald S, Heunks LM, et al. Levosimendan: current data, clinical use and future development. Heart Lung Vessel. 2013;5(4):227\u201345.","journal-title":"Heart Lung Vessel"},{"issue":"6","key":"1928_CR8","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1016\/s0735-1097(00)00961-x","volume":"36","author":"MS Nieminen","year":"2000","unstructured":"Nieminen MS, Akkila J, Hasenfuss G, et al. Hemodynamic and neurohumoral effects of continuous infusion of levosimendan in patients with congestive heart failure. J Am Coll Cardiol. 2000;36(6):1903\u201312. https:\/\/doi.org\/10.1016\/s0735-1097(00)00961-x.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"1928_CR9","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3171\/jns.1978.48.2.0173","volume":"48","author":"B Weir","year":"1978","unstructured":"Weir B, Grace M, Hansen J, Rothberg C. Time course of vasospasm in man. J Neurosurg. 1978;48(2):173\u20138. https:\/\/doi.org\/10.3171\/jns.1978.48.2.0173.","journal-title":"J Neurosurg"},{"issue":"6","key":"1928_CR10","doi-asserted-by":"publisher","first-page":"877","DOI":"10.3109\/02699051003789260","volume":"24","author":"SL Cengiz","year":"2010","unstructured":"Cengiz SL, Erdi MF, Tosun M, et al. Beneficial effects of levosimendan on cerebral vasospasm induced by subarachnoid haemorrhage: an experimental study. Brain Inj. 2010;24(6):877\u201385. https:\/\/doi.org\/10.3109\/02699051003789260.","journal-title":"Brain Inj"},{"issue":"11","key":"1928_CR11","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1007\/s00701-016-2939-5","volume":"158","author":"J Konczalla","year":"2016","unstructured":"Konczalla J, Wanderer S, Mrosek J, et al. Levosimendan, a new therapeutic approach to prevent delayed cerebral vasospasm after subarachnoid hemorrhage? Acta Neurochir (Wien). 2016;158(11):2075\u201383. https:\/\/doi.org\/10.1007\/s00701-016-2939-5.","journal-title":"Acta Neurochir (Wien)"},{"issue":"4","key":"1928_CR12","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1136\/neurintsurg-2021-017504","volume":"14","author":"S Wanderer","year":"2022","unstructured":"Wanderer S, Andereggen L, Mrosek J, et al. Levosimendan as a therapeutic strategy to prevent neuroinflammation after aneurysmal subarachnoid hemorrhage? J Neurointerv Surg. 2022;14(4):408\u201312. https:\/\/doi.org\/10.1136\/neurintsurg-2021-017504.","journal-title":"J Neurointerv Surg"},{"key":"1928_CR13","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.2147\/DDDT.S158237","volume":"12","author":"D Onichimowski","year":"2018","unstructured":"Onichimowski D, Nosek K, Goraj R, et al. Use of levosimendan in the treatment of cerebral vascular vasospasm: a case study. Drug Des Devel Ther. 2018;12:1777\u201383. https:\/\/doi.org\/10.2147\/DDDT.S158237.","journal-title":"Drug Des Devel Ther."},{"issue":"6","key":"1928_CR14","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.accpm.2019.07.004","volume":"38","author":"V Cottenceau","year":"2019","unstructured":"Cottenceau V, Poutier B, Gariel F, et al. May levosimendan be safe and effective in refractory vasospasm despite adequate treatment with repeated angiography and milrinone infusion after subarachnoid haemorrhage? Anaesth Crit Care Pain Med. 2019;38(6):665\u20137. https:\/\/doi.org\/10.1016\/j.accpm.2019.07.004.","journal-title":"Anaesth Crit Care Pain Med"},{"issue":"1","key":"1928_CR15","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1186\/s13054-021-03824-x","volume":"25","author":"A Trinh-Duc","year":"2021","unstructured":"Trinh-Duc A, Labeyrie MA, Caillard A, Ben Hassen W, Mebazaa A, Chousterman BG. Effects of levosimendan on occurrence of cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a case-control study. Crit Care. 2021;25(1):396. https:\/\/doi.org\/10.1186\/s13054-021-03824-x.","journal-title":"Crit Care"},{"key":"1928_CR16","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.neuroimage.2011.09.015","volume":"62","author":"M Jenkinson","year":"2012","unstructured":"Jenkinson M, Beckmann CF, Behrens TE, Woolrich MW. 720 Smith SM FSL. Neuroimage. 2012;62:782\u201390. https:\/\/doi.org\/10.1016\/j.neuroimage.2011.09.015.","journal-title":"Neuroimage"},{"key":"1928_CR17","doi-asserted-by":"publisher","DOI":"10.54294\/uvnhin","author":"B Avants","year":"2009","unstructured":"Avants B, Tustison NJ, Song G. Advanced normalization tools: V1.0. Insight J. 2009. https:\/\/doi.org\/10.54294\/uvnhin.","journal-title":"Insight J."},{"issue":"3","key":"1928_CR18","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s12028-021-01331-z","volume":"35","author":"K Lakhal","year":"2021","unstructured":"Lakhal K, Hivert A, Alexandre PL, et al. Intravenous milrinone for cerebral vasospasm in subarachnoid hemorrhage: the MILRISPASM controlled before-after study. Neurocrit Care. 2021;35(3):669\u201379. https:\/\/doi.org\/10.1007\/s12028-021-01331-z.","journal-title":"Neurocrit Care"},{"issue":"2","key":"1928_CR19","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00234-010-0720-7","volume":"53","author":"JJ Shankar","year":"2011","unstructured":"Shankar JJ, dos Santos MP, Deus-Silva L, Lum C. Angiographic evaluation of the effect of intra-arterial milrinone therapy in patients with vasospasm from aneurysmal subarachnoid hemorrhage. Neuroradiology. 2011;53(2):123\u20138. https:\/\/doi.org\/10.1007\/s00234-010-0720-7.","journal-title":"Neuroradiology"},{"issue":"1","key":"1928_CR20","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/0967-5868(94)90005-1","volume":"1","author":"NW Dorsch","year":"1994","unstructured":"Dorsch NW, King MT. A review of cerebral vasospasm in aneurysmal subarachnoid haemorrhage part I: incidence and effects. J Clin Neurosci. 1994;1(1):19\u201326. https:\/\/doi.org\/10.1016\/0967-5868(94)90005-1.","journal-title":"J Clin Neurosci"},{"issue":"5","key":"1928_CR21","doi-asserted-by":"publisher","first-page":"718","DOI":"10.3171\/jns.1987.66.5.0718","volume":"66","author":"AG Harders","year":"1987","unstructured":"Harders AG, Gilsbach JM. Time course of blood velocity changes related to vasospasm in the circle of Willis measured by transcranial Doppler ultrasound. J Neurosurg. 1987;66(5):718\u201328. https:\/\/doi.org\/10.3171\/jns.1987.66.5.0718.","journal-title":"J Neurosurg"}],"container-title":["Neurocritical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-023-01928-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12028-023-01928-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-023-01928-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T12:15:44Z","timestamp":1724415344000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12028-023-01928-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,7]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["1928"],"URL":"https:\/\/doi.org\/10.1007\/s12028-023-01928-6","relation":{},"ISSN":["1541-6933","1556-0961"],"issn-type":[{"value":"1541-6933","type":"print"},{"value":"1556-0961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,7]]},"assertion":[{"value":"26 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study complies with national and European guidelines on the protection of personal health data (RGPD), as our clinical data warehouse is quality certified in EHDEN. Approval for this study was obtained from the local ethics committee (Comit\u00e9 d\u2019Ethique de la Recherche du Centre Hospitalier Universitaire de Bordeaux). The nonopposition of patients to the use of their data was systematically sought, as required by national regulations for retrospective observational studies.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval\/Informed Consent"}}]}}